SCM
BIIB icon

Sigma Capital Management’s Biogen BIIB Stock Holding History

Sigma Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-32,000
Closed -$9.79M – 16
2014
Q1 		$9.79M Buy
32,000
+22,000
+220% +$6.98M 0.5% 62
2013
Q4 		$2.8M Buy
+10,000
New +$2.59M 0.16% 110
2013
Q3 		– Sell
-37,500
Closed -$8.07M – 289
2013
Q2 		$8.07M Buy
+37,500
New +$8.01M 0.37% 71

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sigma Capital Management's BIIB Position: Q2 2014 in Review

Sigma Capital Management sold out of Biogen (BIIB) in Q2 2014, closing a stake of 32,000 shares — an estimated $9.79M sold.

Sigma Capital Management first reported a position in BIIB in Q2 2013 and held it in 3 quarters. The position peaked at $9.79M in Q1 2014. 782 funds tracked by Wall St. Rank hold BIIB as of Q2 2014.

  • Sigma Capital Management reported no remaining Biogen position as of Q2 2014 after selling out during the quarter.
  • Sigma Capital Management sold 32,000 Biogen shares in Q2 2014, an estimated $9.79M.
  • Sigma Capital Management first reported a position in Biogen in Q2 2013 and held it in 3 quarters.
  • Sigma Capital Management's Biogen position peaked at $9.79M in Q1 2014.
  • 782 funds tracked by Wall St. Rank held Biogen as of Q2 2014.

Based on Sigma Capital Management's 13F filing for Q2 2014.